PPCDC anticorps (N-Term)
Aperçu rapide pour PPCDC anticorps (N-Term) (ABIN629813)
Antigène
Voir toutes PPCDC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- PPCDC antibody was raised against the N terminal of PPCDC
-
Purification
- Purified
-
Immunogène
- PPCDC antibody was raised using the N terminal of PPCDC corresponding to a region with amino acids VTTERAKHFYSPQDIPVTLYSDADEWEIWKSRSDPVLHIDLRRWADLLLV
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PPCDC Blocking Peptide, (ABIN5615490), is also available for use as a blocking control in assays to test for specificity of this PPCDC antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PPCDC antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PPCDC (phosphopantothenoylcysteine Decarboxylase (PPCDC))
-
Autre désignation
- PPCDC
-
Sujet
- Biosynthesis of coenzyme A (CoA) from pantothenic acid (vitamin B5) is an essential universal pathway in prokaryotes and eukaryotes. PPCDC, one of the last enzymes in this pathway, converts phosphopantothenoylcysteine to 4-prime-phosphopantetheine.
-
Poids moléculaire
- 22 kDa (MW of target protein)
-
Pathways
- Ribonucleoside Biosynthetic Process
Antigène
-